APA (7th ed.) Citation

Pink, D., Andreou, D., Bauer, S., Brodowicz, T., Kasper, B., Reichardt, P., . . . Milhem, M. M. (2021). Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient ® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06). Cancers, 13(6), 1223. https://doi.org/10.3390/cancers13061223

Chicago Style (17th ed.) Citation

Pink, Daniel, et al. "Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient ® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)." Cancers 13, no. 6 (2021): 1223. https://doi.org/10.3390/cancers13061223.

MLA (9th ed.) Citation

Pink, Daniel, et al. "Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient ® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)." Cancers, vol. 13, no. 6, 2021, p. 1223, https://doi.org/10.3390/cancers13061223.